Allogeneic adipose-derived mesenchymal stem cells
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Allogeneic adipose-derived mesenchymal stem cells, covering 2015-12-04 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy [Phase 1]